.Pharmacolibrary.Drugs.V_Various.V10B_PainPalliationBoneSeekingAgents.V10BX01_Strontium89srChloride.Strontium89srChloride

Information

name:Strontium89srChloride
ATC code:V10BX01
route:intravenous
n-compartments2

Strontium (89Sr) chloride is a radiopharmaceutical used as a therapeutic agent primarily for the palliation of pain in patients with bone metastases from cancers such as prostate or breast cancer. It is typically administered as an intravenous injection. Strontium-89 mimics calcium and localizes to bone, especially areas of increased osteoblastic activity, delivering localized beta radiation to metastatic lesions. The drug is approved and used mainly in the context of metastatic bone pain palliation.

Pharmacokinetics

Pharmacokinetic profile in adult cancer patients with bone metastases following intravenous administration.

References

    Revisions

    Generated at 2025-07-21T18:21:10Z by OpenModelicaOpenModelica 1.25.1 using GenerateDoc.mos